01/02/2026
๐๐ก๐จ๐ญ๐จ๐๐ข๐จ๐ฆ๐จ๐๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง ๐ญ๐ก๐๐ซ๐๐ฉ๐ฒ ๐๐จ๐ฆ๐๐ข๐ง๐๐ ๐ฐ๐ข๐ญ๐ก ๐ฌ๐ญ๐๐ญ๐ข๐ ๐ฆ๐๐ ๐ง๐๐ญ๐ข๐ ๐๐ข๐๐ฅ๐ ๐ข๐ฌ ๐๐๐ญ๐ญ๐๐ซ ๐ญ๐ก๐๐ง ๐ฉ๐ฅ๐๐๐๐๐จ ๐ข๐ง ๐ฉ๐๐ญ๐ข๐๐ง๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐๐ข๐๐ซ๐จ๐ฆ๐ฒ๐๐ฅ๐ ๐ข๐: ๐ ๐ซ๐๐ง๐๐จ๐ฆ๐ข๐ณ๐๐ ๐ฉ๐ฅ๐๐๐๐๐จ-๐๐จ๐ง๐ญ๐ซ๐จ๐ฅ๐ฅ๐๐ ๐ญ๐ซ๐ข๐๐ฅ
Neide F Ribeiro, CP Ernesto, Douglas S Johnson, Timothy Demchak, Caroline M Machado, B DIAS Luana, Marcelo F De Oliveira, M LINO Matheus, Wesley D RODRIGUES, Jonathan Santo, Carolina N De Barros, Heliodora L Casalechi, Shaiane S Tomazoni
BACKGROUND [...]
AIM
We aimed to investigate the effects of using PBMT-sMF versus a placebo on reduction of the degree-of-pain rating, impact of fibromyalgia, pain intensity, and satisfaction with treatment in patients with fibromyalgia.
DESIGN
A prospectively registered, monocentric, randomized placebo-controlled trial, with blinding of patients, therapists, and assessors, was performed.
SETTING
The study was conducted at the Laboratory of Phototherapy and Innovative Technologies in Health (LaPIT) in Brazil, between March and October 2020.
POPULATION
Ninety female patients with fibromyalgia were randomized to undergo either PBMT-sMF (N.=45) or placebo (N.=45) treatment.
METHODS
Patients from both groups received nine treatment sessions, three times a week, for 3 weeks. Clinical outcomes were collected at baseline, the end of treatment, and at the follow-up appointment 4 weeks post-treatment. The primary outcome was the degree-of-pain rating, measured by the reduction of the tender point count.
RESULTS
A decrease in the degree-of-pain rating was observed in patients allocated to the PBMT-sMF group, decreasing the number of tender points when compared to placebo group at the end of treatment (P